Xconomy’s Digital Events →
Kala is developing particles that can carry drugs through tough mucous membranes.
Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.